" class="no-js "lang="en-US"> Katherine Wilemon - Medtech Alert
Friday, September 05, 2025
Katherine Wilemon

Katherine Wilemon

About Katherine Wilemon

The mission of the FH Foundation is to raise awareness of FH (familial hypercholesterolemia) through education, advocacy, and research. Our goal is to save lives by increasing the rate of early diagnosis and encouraging proactive treatment. If left untreated this life-threatening genetic disorder leads to aggressive cardiovascular disease in men, women, and children of all ethnicities and race.
Join our effort to save lives by increasing early diagnosis and proactive treatment of this life-threatening disease.

Related Story

FDA Approves Repatha ® (evolocumab) in Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia

September 27 2021

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Repatha ® (evolocumab) as an […]